Optimizing Cancer Care with Sidekick’s Human-Centric Digital Therapeutics Programimage placeholder

Optimizing Cancer Care with Sidekick’s Human-Centric Digital Therapeutics Program

This whitepaper focuses on how a DTx solution can mitigate oncology workforce shortages and improve efficiencies in care delivery and the patient experience. It looks at the role of long-term behavior and habits to optimize a cancer treatment plan, and how barriers in the therapy lifecycle can be overcome by re-orienting treatment plans towards prevention and hyper-personalized support, which considers a patient’s sociodemographic variables, physical location, and behavioral patterns. Consider this your companion guide on the capabilities of digital therapeutics, and their ability to deliver a comprehensive illness management solution throughout the care continuum.

by
Bronwyn Hemus and Hanna Kurlanda-Witek
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Download PDF
Oops! Something went wrong while submitting the form.
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
Thank you! This deep dive is ready to watch.
Watch the recording
Oops! Something went wrong while submitting the form.
you may also like
placeholder image
DTx User Acquisition Strategies: Best Practices for Market Access
Cover of Sidekick Health’s whitepaper on FDA’s 2023 draft guidance for Prescription Drug Use-Related Software (PDURS), exploring digital health innovation in Life Sciences across therapeutic areas such as oncology, cardiometabolic conditions, and dermatology.placeholder image
New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences
placeholder image
Nonalcoholic Steatohepatitis (NASH): The ‘Other’ 21st Century Pandemic